Pet Scan

For clinicians who treat patients with Alzheimer’s disease, quantification of amyloid positron emission tomography was feasible and possessed a high degree of concordance with visual analysis, according to a presentation at CTAD.

A comprehensive strategy involving shared cardiac PET scans was associated with better CV outcomes compared with standard care in patients with suspected CAD, according to the results of the CENTURY trial.

In this edition, FDA approves supplemental new drug application for Rexulti, early amyloid PET provides high diagnostic confidence, Leqembi reduced biomarkers of Alzheimer’s and more.

SAN DIEGO — Advances in the ability to measure chronic, active inflammation in MS using MRI and positron emission tomography may improve disease diagnosis and prognosis, according to research presented at ACTRIMS 2023.

A novel CT scan helped physicians identify hormone-producing nodules that cause hypertension, curing some patients of the condition with their removal, according to the results of a prospective, within-patient trial.

Researchers at Emory University are developing a visual tool to view how conditions such as Alzheimer's disease and autism spectrum disorder affect the brain in real-time, the university announced in a press release.

Cerveau Technologies Inc. announced a partnership with Alnylam Pharmaceuticals, which will use Cerveau’s investigational imaging agent in positron emission tomography scans to evaluate neurofibrillary tangles in the brain.

Using noninvasive 18F-sodium fluoride PET and coronary CTA to detect “hot” disease in arteries, researchers were able to predict which patients with recent MI would have recurrent coronary events.

SAN DIEGO — Identifying regions vulnerable to beta-amyloid deposits in younger populations may help predict future accumulation, according to study results presented at the Alzheimer’s Association International Conference.

The FDA granted breakthrough device designation and permitted marketing for the first in vitro diagnostic test for early detection of amyloid plaques associated with Alzheimer’s disease.